Picture of Hyperion DeFi logo

HYPD — Hyperion DeFi News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Eyenovia Re-Acquires Development And Commercialization Rights To Micropine In The U.S. And Canada

Jan 16 (Reuters) - Eyenovia Inc  EYEN.O :
    * EYENOVIA RE-ACQUIRES DEVELOPMENT AND COMMERCIALIZATION
RIGHTS TO
MICROPINE IN THE U.S. AND CANADA
    * EYENOVIA- BY DEAL, CO TO PAY BAUSCH + LOMB IRELAND LIMITED
AN
UPFRONT PAYMENT CONSISTING OF $2 MILLION IN CASH AND $3 MILLION
IN SHARES OF COMMON STOCK
    * EYENOVIA : TO ACCELERATE ONGOING CHAPERONE PHASE III
TRIAL,
ENGAGE WITH FDA TO EXPLORE OPTIONS TO EXPEDITE DEVELOPMENT,
REGISTRATION OF MICROPINE
    * EYENOVIA: TO PAY BAUSCH + LOMB IRELAND LIMITED UPFRONT
PAYMENT
CONSISTING OF $2 MILLION IN CASH, $3 MILLION IN SHARES
    * EYENOVIA: TO PAY BAUSCH + LOMB IRELAND LIMITED LOW
SINGLE-DIGIT
ROYALTY ON EYENOVIA'S NET SALES OF MICROPINE IN UNITED STATES
AND CANADA
    * EYENOVIA INC - AGREEMENT HAS NO IMPACT ON EYENOVIA'S
ONGOING
PARTNERSHIP WITH ARCTIC VISION

Source text for Eikon:  ID:nGNX6S5q7b 
Further company coverage:  EYEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Hyperion DeFi

See all news